Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 7:39:22.
doi: 10.11604/pamj.2021.39.22.28812. eCollection 2021.

2003-2019: explosive spread of enterobacteria producing extended-spectrum beta-lactamases in Bangui Central African Republic

Hugues Sanke-Waïgana  1   2 , Jean-Robert Mbecko  1   2 , Gilles Ngaya  1 , Alexandre Manirakiza  3 , Berlioz-Arthaud Alain  1
Affiliations

2003-2019: explosive spread of enterobacteria producing extended-spectrum beta-lactamases in Bangui Central African Republic

Hugues Sanke-Waïgana et al. Pan Afr Med J. .

Abstract

Introduction: the spread of enterobacteria producing extended-broad-spectrum beta-lactamases (ESBL) is a global public health-problem. In a study carried in 2003-2005 at the Pasteur Institute in Bangui, 450 enterobacteria were identified in clinical isolates, of which 17 were ESBL (prevalence: 3.78%). The aim of this study was to update this data.

Methods: from May 2018 to April 2019, a total of 941 enterobacteria were isolated and identified under identical conditions of recruitment and with the same techniques used in the previous study: phenotypic identification using Api 20E strips (bioMérieux SA, Marcy-l'Etoile, France) and antimicrobial drug susceptibility using the disk diffusion method (Bio-Rad antibiotic discs, Marnes la Coquette, France). Resistance genes were identified by polymerase chain reaction (PCR) and sequencing.

Results: from May 2018 to April 2019, a total of 941 enterobacteria were isolated of which 478 were ESBL, thus amounting to a prevalence of 50.80%. The genetic profiles of the bla CTX-M resistance genes exhibited the emergence of the CTX-M28 variant (CTX-M1 group) and variants of the M2 and M9 groups. There was also a notable increase, from 35 to 64%, in the ESBL with a bla SHV gene.

Conclusion: this study documents a 13 fold increase in the prevalence of ESBL derived from clinical isolates of the bacteriology laboratory of the Institute Pasteur in Bangui, by comparing its data with that of the publication by Frank et al. 2006. Together with this increase a significant diversification of the circulating CTX-M resistance genes was noticed.

Keywords: Antibiotic resistance; Bangui; CTX-M; enterobacteria; extended-spectrum beta-lactamases (ESBL).

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013 Dec;13(12):1057–98. - PubMed
    1. Ashley EA, Lubell Y, White NJ, Turner P. Antimicrobial susceptibility of bacterial isolates from community acquired infections in sub-Saharan Africa and Asian low-and middle-income countries. Trop Med Int Health. 2011 Sep;16(9):1167–79. - PMC - PubMed
    1. Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum beta-lactamase-producing enterobacteriaceae in Europe. Clin Microbiol Infect. 2008 Jan;14(Suppl 1):144–53. - PubMed
    1. Gniadkowski M. Evolution of extended-spectrum beta-lactamases by mutation. Clin Microbiol Infect. 2008 Jan;14(Suppl 1):11–32. - PubMed
    1. Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M type extended-spectrum beta-lactamases. Clin Microbiol Infect. 2008 Jan;14(Suppl 1):33–41. - PubMed

MeSH terms